About Neogen Labs Private Limited
Data last updated: 06 January 2026
Neogen Labs Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 29 June 2006, the company has been in operation for over 20 years.
Registered with ROC Ahmedabad under CIN U33125GJ2006PTC048588.
Capital: an authorised share capital of ₹6 Lakh and a paid-up capital of ₹4.42 Lakh. It is led by directors Aanal Pravin Bhagwati and Pravin Natvarlal Bhagwati.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.62 Cr, a growth of 7% compared to the previous year.
The company has a workforce of approximately 25 employees as per the latest available data.
The company is associated with 1 brand - Neogen Labs. As per MCA filings, the company has satisfied charges of ₹2.41 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neogenlabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address201 Aditya Complex Nr Sardar Patel Sewa Samaj Hall Mithaka, Li, Ahmedabad, Gujarat, India – 380006
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Neogen Labs Private Limited
Neogen Labs Private Limited operates one associated brand: NeoGen Labs. These brands represent Neogen Labs Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Neonatal diagnostic solutions for the detection of inborn errors of metabolism | neogenlabs.com |
Competitors & Alternatives of Neogen Labs Private Limited
Brands and companies operating in the same space as Neogen Labs Private Limited include Natera, Metabolon, SYNLAB and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Natera
|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | Redwood City, United States, United States | 2004 |
Metabolon
|
Solutions for biomarker discovery and diagnostic testing are provided. | Morrisville, United States, United States | 2000 |
SYNLAB
|
Provider of medical diagnosis and clinical laboratory analysis services | Munich, Germany, Germany | 1998 |
3billion
|
AI-driven diagnostic platform for rare genetic diseases is offered. | Seoul, South Korea, South Korea | 2016 |
Beikang Medical
|
NGS-based diagnostic solutions for neonatal screening are developed. | Suzhou, China, China | 2010 |
Progenity
|
Non-invasive prenatal genomic testing is provided for genetic disorders. | San Diego, United States, United States | 2011 |
Blueprint Genetics
|
Genetic diagnostics and clinical interpretation for hereditary diseases are provided. | Espoo, Finland, Finland | 2012 |
Sequenom
|
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered. | San Diego, United States, United States | 1994 |
Yourgene Health
|
Non-invasive prenatal genetic tests and genomic services are provided. | Manchester, United Kingdom, United Kingdom | 2000 |
Ascelia
|
Developer of orphan drugs for treatment and diagnostics solutions | Malmo, Sweden, Sweden | 2000 |
Business Activity of Neogen Labs Private Limited
Neogen Labs Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Auditor Details of Neogen Labs Private Limited
Neogen Labs Private Limited is audited by MILIN J JANI & CO. for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MILIN J JANI & CO. | blur-value | blur-value | blur-value |
Board of Directors of Neogen Labs Private Limited
Neogen Labs Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aanal Pravin Bhagwati | Director | 29 Jun 2006 | 20 Years 0 Months | Current |
|
Pravin Natvarlal Bhagwati
Also directs:
Ved Skills Academy Llp, Bhagwati Autocast Limited, Bhagwati Spherocast Private Limited and 2 more
|
Director | 02 Dec 2013 | 12 Years 7 Months | Current |
Financials of Neogen Labs Private Limited FY 2025 filings available
Neogen Labs Private Limited reported revenue of ₹7.62 Cr (up 7% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Neogen Labs Private Limited
As of FY 2022, Neogen Labs Private Limited's shareholding pattern shows 56.91% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Neogen Labs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2011 | Axis Bank Limited | ₹66 Lakh | Satisfied |
| 15 May 2007 | Bank of Baroda | ₹1.75 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Neogen Labs Private Limited
Neogen Labs Private Limited has a workforce of 25 employees as of Apr 03, 2024.
Employee Count & EPFO Data of Neogen Labs Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Neogen Labs Private Limited
GSTIN & GST Filing Data of Neogen Labs Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Neogen Labs Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Neogen Labs Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Neogen Labs Private Limited
MSME Payment Delays by Neogen Labs Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Neogen Labs Private Limited
Subsidiaries & Group Companies of Neogen Labs Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Neogen Labs Private Limited with ownership details.
MCA Filings & Documents of Neogen Labs Private Limited
MCA Filings & Documents of Neogen Labs Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Neogen Labs Private Limited
Frequently Asked Questions about Neogen Labs Private Limited
Neogen Labs Private Limited is an active private limited company in the healthcare sector based in Ahmedabad, Gujarat, India. It was incorporated on 29 June 2006 (20+ years old) and is registered under CIN U33125GJ2006PTC048588. The company has 25 employees.
Neogen Labs Private Limited reported revenue of ₹7.62 Cr for FY 2025 (up 7.00% YoY).
The current directors of Neogen Labs Private Limited are:
The primary industry of Neogen Labs Private Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Neogen Labs Private Limited can be reached at the registered office: 201 Aditya Complex Nr Sardar Patel Sewa Samaj Hall Mithaka, Li, Ahmedabad, Gujarat, India – 380006, or through the website neogenlabs.com.
The authorised capital is ₹6 Lakh, and the paid-up capital is ₹4.42 Lakh.